News from Avillion LLP A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 30, 2017, 02:05 ET Avillion Signs Clinical Co-development Agreement With Merck to Advance Anti IL-17 A/F Nanobody® in Psoriasis

Avillion LLP, a co-developer and financier of late-stage pharmaceutical product candidates, announces that it has signed a clinical co-development...


Jan 20, 2017, 04:00 ET Avillion Strengthens Clinical and Regulatory Development Capabilities with the Appointment of Mark Weinberg as Chief Medical Officer

Avillion LLP, a co-developer and financier of late-stage pharmaceutical product candidates, announces the appointment of Mark Weinberg, MD MBA as...


Sep 15, 2015, 04:00 ET Avillion Announces Completion of Enrolment in Phase III BFORE Trial to Assess BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia

Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces the completion of enrolment in a global Phase III clinical trial...


Sep 23, 2014, 04:00 ET Avillion Appoints Jarrod Longcor as Chief Business Officer

Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces the appointment of Jarrod Longcor as Chief Business Officer. In this...


Aug 11, 2014, 07:00 ET Avillion Announces Dosing of First Patients in Phase 3 BFORE Trial to Assess BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia

Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a...


Feb 18, 2014, 04:00 ET Avillion Appoints Dr Allison Jeynes-Ellis as Chief Executive Officer

Avillion LLP, a drug development company focused on co-development and financing of late-stage pharmaceutical candidates, from Phase 3 clinical...


May 28, 2013, 10:24 ET Avillion Expands Leadership Team with Appointment of Ramani Varanasi as Chief Business Officer

 Avillion LLP, which focuses on clinical co-development of therapeutics, today announced the expansion of its leadership team with the...


Jan 28, 2013, 03:00 ET Avillion LLP Receives Initial Funding From Abingworth and Clarus

Avillion LLP, which focuses on clinical co-development of therapeutics, today announced that it has received initial funding from Abingworth LLP...